Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large, Multiethnic International Study
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem
PubMed
34212188
DOI
10.1210/clinem/dgab482
PII: 6312926
Knihovny.cz E-zdroje
- Klíčová slova
- CT, MRI, aldosterone, diagnosis, endocrine hypertension, primary aldosteronism,
- MeSH
- adrenalektomie metody MeSH
- aldosteron krev MeSH
- dospělí MeSH
- hyperaldosteronismus diagnostické zobrazování patologie chirurgie MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- magnetická rezonanční tomografie MeSH
- nadledviny krevní zásobení diagnostické zobrazování MeSH
- počítačová rentgenová tomografie MeSH
- retrospektivní studie MeSH
- senzitivita a specificita MeSH
- vény MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Asie MeSH
- Austrálie MeSH
- Evropa MeSH
- Severní Amerika MeSH
- Názvy látek
- aldosteron MeSH
CONTEXT: Adrenal gland imaging is recommended by the current guidelines for the workup of primary aldosteronism (PA). However, its diagnostic performance has not been established in large, multiethnic cohorts of patients who undergo adrenal vein sampling (AVS) and adrenalectomy. OBJECTIVE: This work aims to assess the diagnostic accuracy of cross-sectional adrenal imaging. METHODS: This international multicenter study took place in tertiary referral centers. A total of 1625 PA patients seeking surgical cure were enrolled in an international study involving 19 centers in North America, Europe, Asia, and Australia. Of these, 1311 (81%) had imaging data available and 369 (23%), who received a final diagnosis of surgically cured unilateral PA, were examined. Patients underwent AVS and imaging by computed tomography and/or magnetic resonance imaging. The accuracy of detection of unilateral PA at imaging was estimated by the area under the receiver operator characteristics curve using cure (biochemical and/or full clinical success) as the reference at follow-up after unilateral adrenalectomy. RESULTS: In the cohort of 1311 patients with imaging data available, 34% and 7% of cases showed no detectable or bilateral nodules, respectively. Imaging did not detect the culprit adrenal in 28% of the surgically cured unilateral PA patients. Moreover, the clinical outcome did not differ significantly between the imaging-positive and imaging-negative patients. CONCLUSION: Cross-sectional imaging did not identify a lateralized cause of disease in around 40% of PA patients and failed to identify the culprit adrenal in more than one-fourth of patients with unilateral PA.
3rd Department of Medicine Charles University General Faculty Hospital Prague Czech Republic
AP HP Hôpital Européen Georges Pompidou Hypertension Department and DMU CARTE Paris France
Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan
Department of Internal Medicine Radboud University Medical Center HB Nijmegen the Netherlands
Department of Medicine Monash University Clayton 3168 Victoria Australia
Department of Radiology Radboud University Medical Center HB Nijmegen the Netherlands
Division of Endocrinology and Metabolism Rostock University Medical Center Rostock Germany
Division of Nephrology Endocrinology and Vascular Medicine Tohoku University Hospital Sendai Japan
Endocrinology in Charlottenburg 10627 Berlin Germany
Endocrinology Unit Monash Health Clayton Victoria Australia
Faculty of Medicine University of Ljubljana Ljubljana Slovenia
Foothills Medical Center University of Calgary Calgary Alberta Canada
Heinrich Heine University Düsseldorf Nephrologie 40225 Düsseldorf Germany
Medizinische Klinik und Poliklinik 4 Klinikum der Universität München LMU München Munich Germany
Citace poskytuje Crossref.org
Validation of Existing Clinical Prediction Tools for Primary Aldosteronism Subtyping
ClinicalTrials.gov
NCT01234220